A5034052758- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
- Diabetes Management and Research
- Cardiovascular Health and Disease Prevention
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Heart Rate Variability and Autonomic Control
- Cardiac Imaging and Diagnostics
- Diet and metabolism studies
- Blood Pressure and Hypertension Studies
- Gestational Diabetes Research and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Metabolism, Diabetes, and Cancer
- Cardiovascular Disease and Adiposity
- Pregnancy and preeclampsia studies
- Bariatric Surgery and Outcomes
- Diabetes and associated disorders
- Advanced Glycation End Products research
- Cardiovascular Syncope and Autonomic Disorders
- Pancreatic function and diabetes
- Nutritional Studies and Diet
- Neurological Disorders and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Lipoproteins and Cardiovascular Health
- Peripheral Artery Disease Management
- Diabetes Management and Education
Sorbonne Paris Cité
2015-2024
Université Paris Cité
2015-2024
Assistance Publique – Hôpitaux de Paris
2015-2024
Université Sorbonne Paris Nord
2015-2024
Surface du Verre et Interfaces
2023-2024
Hôpital Jean-Verdier
2014-2023
Sorbonne Université
2003-2022
Hôpital Avicenne
1985-2021
Centre de Recherche en Nutrition Humaine Rhône-Alpes
2008-2021
Karolinska University Hospital
2020
The Cardiovascular Autonomic Neuropathy (CAN) Subcommittee of the Toronto Consensus Panel on Diabetic worked to update CAN guidelines, with regard epidemiology, clinical impact, diagnosis, usefulness testing, and management. is impairment cardiovascular autonomic control in setting diabetes after exclusion other causes. prevalence confirmed around 20%, increases up 65% age duration. Established risk factors for are glycaemic type 1 a combination hypertension, dyslipidaemia, obesity, 2...
The aim of this study was to determine the predictive value silent myocardial ischemia (SMI) and cardiac autonomic neuropathy (CAN) in asymptomatic diabetic patients.We recruited 120 patients with no history infarction or angina, a normal 12-lead electrocardiogram (ECG), two more additional risk factors. SMI assessment carried out by means an ECG stress test, thallium-201 scintigraphy dipyridamole, 48-h monitoring. CAN searched for standardized tests evaluating heart rate variations....
This consensus document provides evidence-based guidelines regarding the evaluation of diabetic cardiovascular autonomic neuropathy (CAN) for human research studies; are result work CAN Subcommittee Toronto Diabetic Neuropathy Expert Group. The subcommittee critically reviewed limitations and strengths available diagnostic approaches need developing new tests function. It was concluded that most sensitive specific currently to evaluate in clinical are: (1) heart rate variability, (2)...
[Figure: see text].
People with diabetes compared people without exhibit worse prognosis if affected by coronavirus disease 2019 (COVID-19) induced the severe acute respiratory syndrome 2 (SARS-CoV-2), particularly when compromising metabolic control and concomitant cardiovascular disorders are present. This Perspective seeks to explore newly occurring cardio-renal-pulmonary organ damage or aggravated process of COVID-19 its implications for risk management diabetes, especially taking into account potential...
Abstract There are substantial advances in understanding disordered gastrointestinal autonomic dysfunction diabetes. It occurs frequently. The underlying pathogenesis is complex involving defects multiple interacting cell types of the myenteric plexus as well. These may be irreversible or reversible. Gastrointestinal symptoms represent a major and generally underestimated source morbidity for escalating health care costs Acute changes glycaemia both determinants consequences altered...
We aimed to evaluate a selective screening strategy for gestational diabetes mellitus (GDM) based on the presence of risk factors: BMI ≥25 kg/m(2), age ≥35 years, family history diabetes, personal GDM, or birth child with macrosomia.Of 20,630 deliveries between 2002 and 2010, we selected 18,775 in women no known whom all factors were known. GDM was universally screened defined as fasting plasma glucose level ≥5.3 mmol/L and/or 2-h postload (75 g) ≥7.8 mmol/L.The prevalence at least one...
To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, is predictive of risk silent myocardial ischemia (SMI) or angiographic coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes. Cohort study 1080 diabetes normal resting electrocardiogram, at least one additional cardiovascular factor density (LDL) cholesterol <3.35 mmol/L. Patients initially underwent screening for...
Abstract Background The relationships between glucose abnormalities, insulin resistance (IR) and heart failure (HF) are unclear, especially regarding to the HF type, i.e., with reduced (HFrEF) or preserved (HFpEF) ejection fraction. Overweight, diabetes hypertension potential contributors IR in persons HF. This study aimed evaluate prevalence of prediabetes a population Vietnamese patients HFrEF HFpEF but no overweight, hypertension, comparison healthy controls, relation severity. Methods We...
<h3>Objective</h3> To test the hypothesis that family dietary coaching would improve nutritional intakes and weight control in free-living (noninstitutionalized) children parents. <h3>Design</h3> Randomized controlled trial. <h3>Setting</h3> Fifty-four elementary schools Paris, France. <h3>Participants</h3> One thousand thirteen (mean age, 7.7 years) 1013 parents 40.5 years). <h3>Intervention</h3> Families were randomly assigned to group A (advised reduce fat increase complex carbohydrate...
The 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Disease (D&CVD) EASD Study Group was held during annual meeting on 30 October 2015 in Munich. This summit organized light recently published and numerous ongoing CVOTs diabetes, which have emerged response to FDA EMA Guidelines. CVOT stands as a novel conference setup, with aim serving reference for all topics related diabetes. Members steering committee D&CVD constitute backbone summit. It included presentations key...
The purpose of this document is to provide clinicians with guidance, using expert consensus, help summarize evidence and offer practical recommendations.Expert Consensus Documents are intended guidance for in areas which there no clinical practice guidelines, especially new evolving tests such as arterial stiffness measurements, until any formal guidelines released.This consensus a source information decision-making guide clinician-patient discussions various scenarios.The goal patients make...